Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2012

Open Access 01-12-2012 | Primary research

Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2/neu receptors of breast carcinoma tissues with derived cell lines

Authors: Behnam Kamalidehghan, Massoud Houshmand, Fereydoun Kamalidehghan, Narges Jafarzadeh, Shahram Azari, Sharifah Noor Akmal, Rozita Rosli

Published in: Cancer Cell International | Issue 1/2012

Login to get access

Abstract

Background

Breast cancer is one of the most common cancers among women throughout the world. Therefore, established cell lines are widely used as in vitro experimental models in cancer research.

Methods

Two continuous human breast cell lines, designated MBC1 and MBC2, were successfully established and characterized from invasive ductal breast carcinoma tissues of Malaysian patients. MBC1 and MBC2 have been characterized in terms of morphology analysis, population doubling time, clonogenic formation, wound healing assay, invasion assay, cell cycle, DNA profiling, fluorescence immunocytochemistry, Western blotting and karyotyping.

Results

MBC1 and MBC2 exhibited adherent monolayer epithelial morphology at a passage number of 150. Receptor status of MBC1 and MBC2 show (ER+, PR+, HER2+) and (ER+, PR-, HER2+), respectively. These results are in discordance with histopathological studies of the tumoral tissues, which were triple negative and (ER-, PR-, HER2+) for MBC1 and MBC2, respectively. Both cell lines were capable of growing in soft agar culture, which suggests their metastatic potential. The MBC1 and MBC2 metaphase spreads showed an abnormal karyotype, including hyperdiploidy and complex rearrangements with modes of 52–58 chromosomes per cell.

Conclusions

Loss or gain in secondary properties, deregulation and specific genetic changes possibly conferred receptor changes during the culturing of tumoral cells. Thus, we hypothesize that, among heterogenous tumoral cells, only a small minority of ER+/PR+/HER2+ and ER+/PR-/HER2+ cells with lower energy metabolism might survive and adjust easily to in vitro conditions. These cell lines will pave the way for new perspectives in genetic and biological investigations, drug resistance and chemotherapy studies, and would serve as prototype models in Malaysian breast carcinogenesis investigations.
Appendix
Available only for authorised users
Literature
1.
Zimonjic D, Brooks MW, Popescu N, Weinberg RA, Hahn WC: Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res. 2001, 61 (24): 8838-PubMed
2.
Hisham A, Yip C: Overview of breast cancer in Malaysian women: a problem with late diagnosis. Asian J Surg. 2004, 27 (2): 130-133. 10.1016/S1015-9584(09)60326-2.CrossRefPubMed
3.
Hisham A, Yip C: Spectrum of breast cancer in Malaysian women: overview. World journal of surgery. 2003, 27 (8): 921-923. 10.1007/s00268-003-6976-x.CrossRefPubMed
4.
Correa C, Bertollo C, Goes A: Establishment and characterization of macl-1 and mgso-3 cell lines derived from human primary breast cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 2009, 17 (10): 473-482. 10.3727/096504009789735404.CrossRef
5.
6.
Osborne C, Hobbs K, Trent J: Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat. 1987, 9 (2): 111-121. 10.1007/BF01807363.CrossRefPubMed
7.
Soule H, Vazguez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973, 51 (5): 1409-PubMed
8.
Engel LW, Young NA: Human breast carcinoma cells in continuous culture: a review. Cancer Res. 1978, 38 (11 Part 2): 4327-PubMed
9.
Keydar I, Chen L, Karby S, Weiss F, Delarea J, Radu M, Chaitcik S, Brenner H: Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer. 1979, 15 (5): 659-670. 10.1016/0014-2964(79)90139-7.CrossRefPubMed
10.
Azari S, Ahmadi N, Tehrani M, Shokri F: Profiling and authentication of human cell lines using short tandem repeat (STR) loci: Report from the National Cell Bank of Iran. Biologicals. 2007, 35 (3): 195-202. 10.1016/j.biologicals.2006.10.001.CrossRefPubMed
11.
12.
Dulbecco R, Freeman G: Plaque production by the polyoma virus. Virology. 1959, 8 (3): 396-10.1016/0042-6822(59)90043-1.CrossRefPubMed
13.
Cailleau R, Olivé M, Cruciger Q: Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro Cellular & Developmental Biology-Plant. 1978, 14 (11): 911-915. 10.1007/BF02616120.CrossRef
14.
Band V, Zajchowski D, Swisshelm K, Trask D, Kulesa V, Cohen C, Connolly J, Sager R: Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res. 1990, 50 (22): 7351-PubMed
15.
Minafra S, Morello V, Glorioso F, La Fiura A, Tomasino R, Feo S, McIntosh D, Woolley D: A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast. Br J Cancer. 1989, 60 (2): 185-10.1038/bjc.1989.248.PubMedCentralCrossRefPubMed
16.
Fogh J: Human tumor lines for cancer research. Cancer Investigation. 1986, 4 (2): 157-184. 10.3109/07357908609038260.CrossRefPubMed
17.
Pettengill O, Lewko W: Cell culture of human metastatic breast carcinomas: a review. Molecular Biotherapy. 1989, 1 (3): 122-PubMed
18.
19.
Amadori D, Bertoni L, Flamigni A, Savini S, Giovanni C, Casanova S, Paola F, Amadori A, Giulotto E, Zoli W: Establishment and characterization of a new cell line from primary human breast carcinoma. Breast Cancer Res Treat. 1993, 28 (3): 251-260. 10.1007/BF00666586.CrossRefPubMed
20.
Vandewalle B, D’Hooghe M, Savary J, Vilain M, Peyrat J, Deminatti M, Delobelle-Deroide A, Lefebvre J: Establishment and characterization of a new cell line (VHB-1) derived from a primary breast carcinoma. J Cancer Res Clin Oncol. 1987, 113 (6): 550-558. 10.1007/BF00390864.CrossRefPubMed
21.
Shen C, Gu M, Liang D, Miao L, Hu L, Zheng C, Chen J: Establishment and characterization of three new human breast cancer cell lines derived from Chinese breast cancer tissues. Cancer Cell International. 2009, 9 (1): 2-10.1186/1475-2867-9-2.PubMedCentralCrossRefPubMed
22.
Zoli W, Roncuzzi L, Flamigni A, Gruppioni R, Sensi A, Zini N, Amadori D, Gasperi-Campani A: A new cell line from human infiltrating ductal carcinoma of the breast: establishment and characterization. J Cancer Res Clin Oncol. 1996, 122 (4): 237-242. 10.1007/BF01209652.CrossRefPubMed
23.
Meltzer P, Leibovitz A, Dalton W, Villar H, Kute T, Davis J, Nagle R, Trent J: Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification. Br J Cancer. 1991, 63 (5): 727-10.1038/bjc.1991.164.PubMedCentralCrossRefPubMed
24.
Engel L, Young N, Tralka T, Lippman M, O’Brien S, Joyce M: Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res. 1978, 38 (10): 3352-PubMed
25.
Hambly R, Double J, Thompson M, Bibby M: Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude mice. Breast Cancer Res Treat. 1997, 43 (3): 247-258. 10.1023/A:1005756632293.CrossRefPubMed
26.
Han J, Crowe D: Tumor initiating cancer stem cells from human breast cancer cell lines. Int J Oncol. 2009, 34 (5): 1449-PubMed
27.
Reile H, Birnböck H, Bernhardt G, Spruß T, Schönenberger H: Computerized determination of growth kinetic curves and doubling times from cells in microculture. Anal Biochem. 1990, 187 (2): 262-267. 10.1016/0003-2697(90)90454-H.CrossRefPubMed
28.
Cailleau R, Young R, Olive M, Reeves W: Breast tumor cell lines from pleural effusions. J Natl Cancer Inst. 1974, 53 (3): 661-PubMed
29.
Ito I, Yoshimoto M, Iwase T, Watanabe S, Katagiri T, Harada Y, Kasumi F, Yasuda S, Mitomi T, Emi M: Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br J Cancer. 1995, 71 (3): 438-10.1038/bjc.1995.89.PubMedCentralCrossRefPubMed
30.
Warburg O: On respiratory impairment in cancer cells. Science. 1956, 124 (3215): 269-270.PubMed
31.
Vander Heiden MG, Cantley LC, Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science’s STKE. 2009, 324 (5930)): 1029-
32.
Kroemer G, Pouyssegur J: Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell. 2008, 13 (6): 472-482. 10.1016/j.ccr.2008.05.005.CrossRefPubMed
Metadata
Title
Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2/neu receptors of breast carcinoma tissues with derived cell lines
Authors
Behnam Kamalidehghan
Massoud Houshmand
Fereydoun Kamalidehghan
Narges Jafarzadeh
Shahram Azari
Sharifah Noor Akmal
Rozita Rosli
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2012
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-12-43

Other articles of this Issue 1/2012

Cancer Cell International 1/2012 Go to the issue

Review

New insights into antigen specific immunotherapy for chronic myeloid leukemia

Primary research

Molecular network profiling of U373MG human glioblastoma cells following induction of apoptosis by novel marine-derived anti-cancer 1,2,3,4-tetrahydroisoquinoline alkaloids

Primary research

ZIP8 expression in human proximal tubule cells, human urothelial cells transformed by Cd+2 and As+3 and in specimens of normal human urothelium and urothelial cancer

Primary research

Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines

Primary research

Folic acid supplementation increases survival and modulates high risk HPV-induced phenotypes in oral squamous cell carcinoma cells and correlates with p53 mRNA transcriptional down-regulation

Primary research

The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits